16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
19
Exploring Arylidene-Indolinone Ligands of Autophagy Proteins LC3B and GABARAP.

Tufts University
1
PCSK9 Targeted Autophagosome-Tethering Compounds: Design, Synthesis, and Antiatherosclerosis Evaluation.

Fudan University
32
Autophagy modulation in cancer therapy: Challenges coexist with opportunities.

Sichuan University
2
Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations.

Hangzhou Institute for Advanced Study
1
Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy.

Fudan University
4
Targeted Degradation of PCSK9 In Vivo by Autophagy-Tethering Compounds.

Fudan University
30
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor.

Fudan University
19
Facilitating the development of molecular glues: Opportunities from serendipity and rational design.

Sichuan University
1
Targeting EGFR degradation by autophagosome degraders.

Jinan University
14
Discovery of Novel PDEδ Autophagic Degraders: A Case Study of Autophagy-Tethering Compound (ATTEC).

East China University of Science and Technology
3
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides.

Sun Yat-Sen University
72
The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease.

Aligarh Muslim University
10
Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT).

Second Military Medical University
55
Demonstrating Ligandability of the LC3A and LC3B Adapter Interface.

Goethe-University Frankfurt
13
M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

Lycia Therapeutics
9
LSD1 inhibitors and medical uses thereof

Constellation Pharmaceuticals